Indication

Microscopic polyangiitis

Microscopic polyangiitis is a rare, systemic autoimmune disease characterized by necrotizing vasculitis that predominantly targets small-caliber blood vessels, including arterioles, capillaries, and venules. Read more about Microscopic polyangiitis

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Microscopic polyangiitis therapies.

Showing 1–4 of 4 drugs

RITUXAN (rituximab)

ANTINEOPLASTIC MONOCLONAL ANTIBODIES·RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA·+10
GENENTECH

RUXIENCE (rituximab-pvvr)

ANTINEOPLASTIC MONOCLONAL ANTIBODIES·RELAPSE OR REFRACTORY NON-HODGKIN'S LYMPHOMA·+7
Parke-Davis Pfizer

TAVNEOS (avacopan)

COMPLEMENT INHIBITORS·GRANULOMATOSIS WITH POLYANGIITIS·+1
CHEMOCENTRYX/AM
Filter & compare in the drug finder →Opens the drug finder with Microscopic polyangiitis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Microscopic polyangiitis.

Microscopic polyangiitis is a rare, systemic autoimmune disease characterized by necrotizing vasculitis that predominantly targets small-caliber blood vessels, including arterioles, capillaries, and venules.

As a form of antineutrophil cytoplasmic antibody-associated vasculitis, it classically demonstrates pauci-immune vascular inflammation—marked by minimal or absent immune deposit formation—and most frequently associates with circulating myeloperoxidase-specific autoantibodies.

Although the condition can affect individuals of any age across diverse organ systems, it most commonly presents in middle-aged to older adults with rapidly progressive glomerulonephritis, alveolar hemorrhage secondary to pulmonary capillaritis, systemic constitutional symptoms, and peripheral neuropathy.

Unlike related vasculitides, microscopic polyangiitis is histopathologically defined by the absence of granulomatous inflammation.

Personalize your experience

Follow Microscopic polyangiitis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it